Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the impact of a structured package (bundle) in reducing the use of antimicrobials and hospital stay of patients with community-acquired pneumonia (CAP), and no increase in mortality of these patients in different hospitals.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pre-intervention All patients admitted with a diagnosis of CAP | |||
| Post intervention All patient admitted with a diagnosis of CAP |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Antimicrobial use in patients hospitalized for CAP. | It is measured in defined daily doses (DDD) per 100 hospital stay of patients hospitalized with CAP. | twelve months |
| Mortality rate to 30 days | Number of death of patients hospitalized with CAP, stratified by CURB-65 score. | twelve months |
| Measure | Description | Time Frame |
|---|---|---|
| CAP severity CURB-65 or PSI registered. | Implementation of quality indicators in the management of CAP. They are expressed as dichotomous variables (yes / no): Numbers of doctors who register on the clinical history the evaluation of CAP severity by CURB-65 or PSI at hospitalization. | twelve months |
| Microbiological samples at admission. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Pre-intervention period
All patients admitted with a diagnosis of CAP will be included in the participating centers during the 12 months prior to the intervention. Case detection is done through the electronic record of the basic minimum data set (MDS) (2, 36). Diagnosed patients will be selected at discharge: "simple acute bronchitis and pneumonia excluding asthma major criteria" (by diagnosis related group, DRG 541) and "simple and pleuritis in over 17 Pneumonia" (DRG 089).
Post-intervention period
All patients admitted with a diagnosis of CAP in the participating centers, which measures the bundle will apply prospectively included. Case detection was performed by daily review of patients admitted to target units and will be coordinated by the IP address of each center.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pilar Retamar Gentil | Contact | 0034 955 04 04 50 | gestionensayosclinicos.fps@juntadeandalucia.es |
| Name | Affiliation | Role |
|---|---|---|
| Pilar Retamar Gentil | Hospital Universitario Virgen Macarena | Study Director |
| Juan Enrique Corzo Delgado | Hospital Universitario Virgen de Valme | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fundación Pública Progreso y Salud | Recruiting | Seville | Sevilla | 41092 | Spain |
Not provided
| ID | Term |
|---|---|
| D000098968 | Community-Acquired Pneumonia |
| ID | Term |
|---|---|
| D017714 | Community-Acquired Infections |
| D007239 | Infections |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Implementation of quality indicators in the management of CAP. They are expressed as dichotomous variables (yes / no): Numbers of doctors who taking all microbiological samples recommended in the guideline in the first 6 hours of patient admission. |
| twelve months |
| Appropriate supportive treatment | Implementation of quality indicators in the management of CAP. They are expressed as dichotomous variables (yes / no): Number of doctors who take supportive treatment according to guideline during the hospitalization. | Twelve months |
| Empirical treatment | Implementation of quality indicators in the management of CAP. They are expressed as dichotomous variables (yes / no): Number of doctors who prescribed empirical treatment according to the guideline at admission. | Twelve months |
| Appropriate sequential therapy. | Implementation of quality indicators in the management of CAP. They are expressed as dichotomous variables (yes / no): Number of doctors who switch to oral therapy according to guideline. | Twelve months |
| Specific antimicrobial treatment | Implementation of quality indicators in the management of CAP. They are expressed as dichotomous variables (yes / no): Number of doctors who prescribed the specific antimicrobial treatment defined in the guideline | Twelve months |
| Total duration of antibiotic therapy. | Implementation of quality indicators in the management of CAP. They are expressed as dichotomous variables (yes / no): Number of doctors who prescribe an antimicrobial treatment during 7 days or less, or 5 days or less after clinical improvement. | Twelve months |
| Cristina Roca Oporto |
| Hospitales Universitarios Virgen del Rocío |
| Principal Investigator |
| Montserrat Pérez Pérez | Hospital de la Línea de la Concepción | Principal Investigator |
| Salvador López Cardenas | Hospital de Jerez de la Frontera | Principal Investigator |
| María del Carmen Almodóvar Pulido | Hospital de Antequera | Principal Investigator |
| Fernando Nebrera Navarro | Hospital de Formentera | Principal Investigator |
| Rosario Javier Martínez | University Hospital Virgen de las Nieves | Principal Investigator |
| Francisca Guerrero Sánchez | Hospital Universitario Puerta del Mar | Principal Investigator |
| D012140 |
| Respiratory Tract Diseases |